Hexagon Bio Funding: $323M Raised, Series B (2023)

Hexagon Bio funding overview

Hexagon Bio is based in Menlo Park, California. Hexagon Bio has raised $323M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in February 2023. The round record for Hexagon Bio runs through 2023; nothing later has been disclosed. Investors on record include 8VC, The Column Group, Two Sigma Ventures, Nextech, Canada Pension Plan Investment Board (CPP Investments), Colle Capital and 5 others. 11 distinct backers are named across the disclosed rounds.

Hexagon Bio at a glance

Total raised: $323M
Latest round: Series B
Latest round date: February 2023
Headquarters: Menlo Park, California
Notable investors: 8VC, The Column Group, Two Sigma Ventures, Nextech, Canada Pension Plan Investment Board (CPP Investments), Colle Capital, FF Venture Capital, Shasta Ventures

Frequently asked about Hexagon Bio funding

How much has Hexagon Bio raised?: Hexagon Bio has raised $323M in total disclosed funding across the rounds on record.
Who has invested in Hexagon Bio?: 8VC, The Column Group, Two Sigma Ventures, Nextech, Canada Pension Plan Investment Board (CPP Investments), Colle Capital are named among the investors backing Hexagon Bio.
What was the latest Hexagon Bio funding round?: The most recent disclosed round is a Series B, announced in February 2023.
Where is Hexagon Bio based?: Hexagon Bio is based in Menlo Park, California.
When did Hexagon Bio last raise?: The last disclosed Hexagon Bio round closed in February 2023 at Series B.

Every Hexagon Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Menlo Park at a similar stage.

Hexagon Bio Funding: $323M Raised, Series B (2023)

Hexagon Bio funding overview

Hexagon Bio at a glance

Frequently asked about Hexagon Bio funding

Companies related to Hexagon Bio (34)

Browse related funding lists (4)